Rad Onc Twitter

  • Thread starter Thread starter deleted1002574
  • Start date Start date
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Spratt being such a jerk to his colleagues, unnecessarily, all the time, is going to limit his upward career trajectory, as it absolutely should.
I initially had the same reaction but - will it really? Ralph seems to be doing OK. Spratt made it to Chair of a department - it might not be the most "prestigious" department, but he's already in a small group of people at that level.

In a fair world, maybe, but...
 
I expect him to be not nice. That’s his way of interacting with others, especially if he doesn’t respect them.

I agree that SBRT is cheaper. How much cheaper matters? A lot of times you have absolute costs and estimates, and when you run the numbers, you see that it doesn’t come out the way you think it does.

I think when discussing things like, ya know, money, accuracy matters.
 
I think when discussing things like, ya know, money, accuracy matters.
I think accuracy regarding cost might be impossible (Scarbs whole point on twitter I think?). The value is just not well defined.

I doubt that any academic chair, large non-profit academic institution, community hospital, for-profit hospital or private practice is deeply motivated to provide the most "value based" care in the present model.

The govt is motivated regarding this but is inept. Everybody knows it's the pricing more than what you do. Pricing is arbitrary AF and is overwhelmingly where the financial toxicity comes from. The APM was poorly conceived but the basic premise of incentivizing docs towards value based care was right. Applying pricing rules most of us already have to PPS exempt places would of course provide major savings.

The Norwegians are motivated regarding value-based care because of their health care model. Not surprisingly, as @TheWallnerus posted, they found very little value to adding a presumed safety measure (SPACEOAR) with some inherent toxicity to a prohibitively safe intervention to begin with.
 
I think accuracy regarding cost might be impossible (Scarbs whole point on twitter I think?). The value is just not well defined.

I doubt that any academic chair, large non-profit academic institution, community hospital, for-profit hospital or private practice is deeply motivated to provide the most "value based" care in the present model.

The govt is motivated regarding this but is inept. Everybody knows it's the pricing more than what you do. Pricing is arbitrary AF and is overwhelmingly where the financial toxicity comes from. The APM was poorly conceived but the basic premise of incentivizing docs towards value based care was right. Applying pricing rules most of us already have to PPS exempt places would of course provide major savings.

The Norwegians are motivated regarding value-based care because of their health care model. Not surprisingly, as @TheWallnerus posted, they found very little value to adding a presumed safety measure (SPACEOAR) with some inherent toxicity to a prohibitively safe intervention to begin with.
Absolutely. That's why looking at sticker prices and saying something is cost effective or not is not "scientific" and should have some push back / debate.
 

Where Dan lost credibility a little is when he was like Medicare is 60% to 70% of all patients at cancer centers whereas his common refrain prior to this (when talking about the terrible maldistribution of work and patients in rad onc) was that he didn’t treat many Medicare patients.
 
Where Dan lost credibility a little is when he was like Medicare is 60% to 70% of all patients at cancer centers whereas his common refrain prior to this (when talking about the terrible maldistribution of work and patients in rad onc) was that he didn’t treat many Medicare patients.
Very innocuous post to block
 
Based on that twitter pic, scarb is clearly in the Caymans. And I think I have a pic of KHE there as well:
1642434620015.png

Mystery solved...
 

Not sure if here or "breast is the worst" thread but here's the latest gem from my local Genesis:
Have others seen this? 28 fx wbrt with sib. Aka, 28 fx whole breast imrt.
 
Last edited:
I am bewildered by this Twitter exchange. What is happening right now??
Best as I can tell if Dan says RT is cheap and someone says “no it can actually be 10x more than what you say Dan,” then you hate radiation oncology. And as usual Simul calls it correctly.
 


Wow. Insecurity is one thing, but straight unkindness. Eh. Hurt people hurt people.

You are our respected leader Simul. We are so small and fringe and anonymous.

“I am just a simple rad onc”

Dan actually kind of looks like unfrozen caveman lawyer, “I am just a simple caveman”

 


Wow. Insecurity is one thing, but straight unkindness. Eh. Hurt people hurt people.

D-Baggery at its finest here.

I don't know Spratt (or Simul) and maybe he's fine, but his Twitter feed lately is sounding like someone who has realized that:

1. He's still just a radonc. (I think this hits the ascendant young chairs hard some times. Time to spend lots of your energy building relationships with people outside of the department, and the real chairs don't give a damn about incremental changes in radiation guidelines.)

2. Cleveland Clinic is pretty well respected in GU oncology.
 
I am bewildered by this Twitter exchange. What is happening right now??
Look, as long as I have my fans of fringe internet people, I'll be okay 🙂

I don't know. He really dislikes me, I think. It is getting quite personal for him. It happens when we interact. Jealousy? Other than my wife and kids, this incredible biryani in 2019 and this one awesome Insta post from my Croatia trip, I haven't really accomplished that much compared to him, so it's probably not that. Insecurity? I respect the guy, always have, but not when he turns into this person.

1. I think pointing out the prices is important - if we want to talk about cost effectiveness, numbers matter.
2. Writing this up would be a good resident project - maybe salty didn't think of it first? Great data to have at tumor board.
3. Pointing out that $7500-10000 is way too low doesn't mean you are slamming RO as a modality.
4. Twitter expert seems like a nice thing to say, but I think he's being sarcastic.
5. Small? Maybe. Fringe? I don't know about that.
6. I didn't do any prostate cancer work. Is he literally quoting his own body of work to try to make me look bad? That's an interesting move.

As the kids say, I think he has "no chill."
 
what an absolute insane thing to tweet. posting this here for posterity because with Spratt you never know when he is going to delete:





edit: oops, missed all the posts above.
 



subtweet at spratt

I mean, probably not just at Spratt. Over the last two weeks, we've had all the lovely conversations with people like Ralph/Drew/the thoracic surgeons/the Urologists etc. It hasn't exactly been very congenial/professional...but it's not like it ever was.

Is there anyone left wondering why SDN remains so popular in Radiation Oncology? Why would anyone want to wade in the filth that is RadOnc Twitter? Is this what we want on display for patients and medical students?

But you know, we're the misanthropes.
 
Wasn’t there a time when Spratt was heavily praised for coming on here and telling us how great his program is going to be while avoiding any rationale reason to decrease the number of residency positions?

If I recall, I do remember saying that he wasn’t for the cause and how his responses were heavily filled with fluff and BS. Now I could be mistaking him for someone else… I’m just too lazy to check.
 
1) This is so Ralph, obviously.

2) To see what he's responding to:

View attachment 348341

3) The surgeons on Twitter sure are an interesting bunch. Is this guy gunning for Cooperberg's crown of "I don't understand the nuance of medicine"?

I wish the academic surgeons (and the RadOncs, and everyone really) would come out into the communities where there's a lot of generalists and see what it's like. Yes, if you're at a high-volume academic center with dedicated thoracic surgical oncologists, things are probably good. If you're in an area where you have "surgeons who operate in the thorax"...I can ASSURE you, SBRT is a reasonable option, even if you're a surgical candidate.

It saves me from having to do some creative treatment planning because there's a giant recurrence along the theranostic suture line from the "resection". Please stop making me do that.
Oh god I had to do that once. DID NOT LIKE.
 
Was never really a fan of Dr Spratt when he was posting on this forum. Always thought there was a lot of arrogance in the way he was posting on here and on Twitter. I don’t know him personally or professionally but he definitely comes across as someone I would never want to work for.
 
Was never really a fan Dr Spratt when he was posting on this forum. Always thought there was a lot of arrogance in the way he posted here and on Twitter. I don’t know him personally or professionally but he definitely comes across as someone I would never want to work for.
Or with. God help him if he ever decides to leave academics....
 
There appears to be a high correlation between people on Twitter who espouse their superiority for expressing their opinion non-anonymously and people on Twitter who block those who disagree with their expressed opinion.

Interesting.

Most interesting part of that post was Abi for $200/month. Didn’t believe it as last time I checked it was still 3-5k on good rx. Now down to $200 at Safeway and 300$ at Costco. That is absolutely huge.

Pretty hard to justify 12k/month for apa/darolutamide just to avoid taking a bit of prednisone. It seems obvious that any indication we can we should pick Abi first. The only other question is what about the indications where Abi isn’t proven (like nmCRPC) but probably works just as well given everything else we know, do we just give it.
 
Was never really a fan of Dr Spratt when he was posting on this forum. Always thought there was a lot of arrogance in the way he was posting on here and on Twitter. I don’t know him personally or professionally but he definitely comes across as someone I would never want to work for.
I feel the same way about Dan Spratt that I do about Kanye West.

I enjoy and respect their work, but they're not the kind of people I want to know personally.

I know Spratt and others blame Simul and SDN for RadOnc's "fall from grace". I'm sure that drove a lot of today's vitriol. So, to turn it around, if someone reading my words right now feels that way - why?

As we have clearly seen, though the Match rate for RadOnc is low, virtually all spots are being filled through other mechanisms.

Those spots, by definition, are going to physicians. Those physicians are, by definition, people who have successfully completed medical school and are eligible (or have already completed) all the steps required to be licensed to practice medicine in the United States.

Are you worried these physicians are not going to be able to complete our residency training and pass our 4 board exams? If they are able to complete medical school and pass all of the USMLE exams, yet struggle with RadOnc - is that a problem with them, or our training/board certification process? There is nothing inherently special or more difficult about Radiation Oncology compared to any other specialty in medicine. Any person capable of graduating medical school and completing the steps required for a medical license should be able to become board certified in RadOnc.

Are you worried that these physicians are not the historical "rock stars" of the past 15-20 years, and we're not going to be able to have the impact on medicine that we used to have? For all of our MD-PhD, AOA, 20+ publication medical students we've Matched - what do we have to show for it? While our Match stats are "better", has that translated to a more powerful impact later on? There doesn't appear to be much of a correlation.

Are practice patterns and reimbursement trends moving in a positive direction, or a neutral-to-negative one? We have some of the worst wage stagnation in all of medicine. I need to double check the numbers, but I believe CMS has cut our reimbursement ~25% compared to a decade ago. Our major innovation over the last 10 years is reducing the number of fractions we use to treat cancer, which, while amazing for patients, has a direct impact on the "demand" side of our specialty.

Are leadership positions being made available to the next generation? Or are the majority of people in Chair or Vice Chair positions the people that have been in that role for 15, 20, 25+ years?

When private practice docs are retiring, are they handing the reigns off to the next generation, or are they selling their practice to hospitals/academic systems?

For the early-to-mid career "academic" docs, what does their day-to-day look like? Are they at the main campus, with protected academic time and appropriate resources to grow an academic career? Or are they relegated to satellite sites, functioning essentially as community docs for academic pay and little chance for advancement, since their "academic time" is from 5PM-9PM?

If you are one of the people who believes RadOnc has "fallen from grace", you need to check your hubris at the door.

1) We have virtually the same number of residency spots and programs as we did 5 years ago (perhaps more)
2) We are filling virtually all those spots with physicians

If physicians who were eligible to fill a residency spot are struggling to finish residency or pass board exams, whereas 5 years ago they were not - that means your training program is bad and you were previously surviving because you Matched people who were good at taking tests. You don't deserve to have residents.

If your training program can produce board-certified graduates but people aren't applying to your program - that means there are concerns about the career itself. If you believe a graduating medical student in 2022 can have a vibrant career in RadOnc - a career that could span 30-40 years - why do you believe that? Are you pointing at an ARRO jobs survey filled out by residents yet to graduate, or word of mouth from your friends, or something more substantial? We'd all love to know.

Until and unless available spots in Radiation Oncology are not being filled at all, then Dan Spratt and everyone else has the raw material they need to prove everyone wrong.

I'll be here, waiting. I want to be proven wrong.
 
Pretty hard to justify 12k/month for apa/darolutamide just to avoid taking a bit of prednisone.
Also bothersome how NRG initially included apa in addition to Abi into clinical trials looking at expansion of next gen endocrine therapy in the salvage/high risk space (GU008 and 009 (now revised I believe)). This when there is some uncertainty regarding "how low to go" with abi (as is clear in one of Spratt's tweets). Folks coming up with the NRG trial design should be criticized for this IMO.
 
Come on man,
You watchin' Monday Night Football?
Most interesting part of that post was Abi for $200/month.
I know right.
I'll be here, waiting. I want to be proven wrong.
Dan Spratt: "60-70% of all patients in cancer centers are Medicare patients."
Proven wrong (by himself from old tweets).
Dan Spratt: "SBRT is less than $10K."
Proven wrong.
Dan Spratt: "Abiraterone is thousands of dollars a month."
Proven wrong.

C'mon man!
 
You watchin' Monday Night Football?

I know right.

Dan Spratt: "60-70% of all patients in cancer centers are Medicare patients."
Proven wrong (by himself from old tweets).
Dan Spratt: "SBRT is less than $10K."
Proven wrong.
Dan Spratt: "Abiraterone is thousands of dollars a month."
Proven wrong.

C'mon man!
@Dan Spratt ?
 
You are our respected leader Simul. We are so small and fringe and anonymous.

“I am just a simple rad onc”

Dan actually kind of looks like unfrozen caveman lawyer, “I am just a simple caveman”


Simul is our nonanonymous voice perhaps, but I think most of us opted for the job we have to get away from "respected leaders."
 
Top